CN112813126B - 一种火麻仁粕蛋白多肽液的生产方法和一种具有降尿酸作用的多肽液及其应用 - Google Patents
一种火麻仁粕蛋白多肽液的生产方法和一种具有降尿酸作用的多肽液及其应用 Download PDFInfo
- Publication number
- CN112813126B CN112813126B CN202110154677.0A CN202110154677A CN112813126B CN 112813126 B CN112813126 B CN 112813126B CN 202110154677 A CN202110154677 A CN 202110154677A CN 112813126 B CN112813126 B CN 112813126B
- Authority
- CN
- China
- Prior art keywords
- enzymolysis
- polypeptide liquid
- fructus cannabis
- polypeptide
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 99
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 96
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 96
- 239000007788 liquid Substances 0.000 title claims abstract description 89
- 235000012054 meals Nutrition 0.000 title claims abstract description 57
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract description 44
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 229940116269 uric acid Drugs 0.000 title claims abstract description 44
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 27
- 230000001603 reducing effect Effects 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 240000004308 marijuana Species 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 56
- 108090000790 Enzymes Proteins 0.000 claims abstract description 56
- 241000218236 Cannabis Species 0.000 claims abstract description 42
- 238000000855 fermentation Methods 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 28
- 108091005658 Basic proteases Proteins 0.000 claims abstract description 26
- 230000004151 fermentation Effects 0.000 claims abstract description 25
- 230000000415 inactivating effect Effects 0.000 claims abstract description 13
- 238000009210 therapy by ultrasound Methods 0.000 claims abstract description 6
- 229940088598 enzyme Drugs 0.000 claims description 55
- 239000011550 stock solution Substances 0.000 claims description 43
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 38
- 239000004365 Protease Substances 0.000 claims description 35
- 244000025254 Cannabis sativa Species 0.000 claims description 30
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 30
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 30
- 235000009120 camo Nutrition 0.000 claims description 30
- 235000005607 chanvre indien Nutrition 0.000 claims description 30
- 239000011487 hemp Substances 0.000 claims description 30
- 238000002156 mixing Methods 0.000 claims description 30
- 108091005804 Peptidases Proteins 0.000 claims description 23
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 21
- 235000019419 proteases Nutrition 0.000 claims description 21
- 241000894006 Bacteria Species 0.000 claims description 19
- 239000004310 lactic acid Substances 0.000 claims description 19
- 235000014655 lactic acid Nutrition 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 16
- 241000186660 Lactobacillus Species 0.000 claims description 13
- 229940039696 lactobacillus Drugs 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000004506 ultrasonic cleaning Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 7
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 7
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 claims description 7
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 7
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 7
- 108010004032 Bromelains Proteins 0.000 claims description 6
- 108090000526 Papain Proteins 0.000 claims description 6
- 235000019835 bromelain Nutrition 0.000 claims description 6
- 235000019834 papain Nutrition 0.000 claims description 6
- 229940055729 papain Drugs 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 108010007119 flavourzyme Proteins 0.000 claims description 5
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000002525 ultrasonication Methods 0.000 claims description 3
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 abstract description 13
- 229960003459 allopurinol Drugs 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 7
- 108010093894 Xanthine oxidase Proteins 0.000 abstract description 5
- 102100033220 Xanthine oxidase Human genes 0.000 abstract description 5
- 230000000975 bioactive effect Effects 0.000 abstract description 3
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 abstract 1
- 239000013641 positive control Substances 0.000 abstract 1
- 238000004537 pulping Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 23
- 230000009849 deactivation Effects 0.000 description 16
- 238000004007 reversed phase HPLC Methods 0.000 description 15
- 238000005520 cutting process Methods 0.000 description 7
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 6
- 201000005569 Gout Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000007865 diluting Methods 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000001431 Hyperuricemia Diseases 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001976 enzyme digestion Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- 229940075420 xanthine Drugs 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110154677.0A CN112813126B (zh) | 2021-02-04 | 2021-02-04 | 一种火麻仁粕蛋白多肽液的生产方法和一种具有降尿酸作用的多肽液及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110154677.0A CN112813126B (zh) | 2021-02-04 | 2021-02-04 | 一种火麻仁粕蛋白多肽液的生产方法和一种具有降尿酸作用的多肽液及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112813126A CN112813126A (zh) | 2021-05-18 |
CN112813126B true CN112813126B (zh) | 2022-11-29 |
Family
ID=75861366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110154677.0A Active CN112813126B (zh) | 2021-02-04 | 2021-02-04 | 一种火麻仁粕蛋白多肽液的生产方法和一种具有降尿酸作用的多肽液及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112813126B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4321036A1 (en) * | 2021-04-05 | 2024-02-14 | Amano Enzyme Europe Ltd. | Method for manufacturing processed hemp beverage/foodstuff or foodstuff material |
CN114145463A (zh) * | 2021-10-25 | 2022-03-08 | 东北农业大学 | 一种复合酶解制备低苦味火麻仁肽的方法 |
CN114540450B (zh) * | 2022-03-07 | 2023-08-01 | 黑龙江省科学院大庆分院 | 一种调节hprt1基因和oat1蛋白的汉麻仁生物活性肽及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104480177B (zh) * | 2014-12-31 | 2018-05-04 | 广西壮族自治区农业科学院农产品加工研究所 | 一种火麻蛋白ace抑制肽的制备方法 |
CN104489837B (zh) * | 2014-12-31 | 2016-04-20 | 广西壮族自治区农业科学院农产品加工研究所 | 一种火麻蛋白肽饮料及其制备方法 |
CN106177339A (zh) * | 2016-08-26 | 2016-12-07 | 广西本草坊保健品有限公司 | 一种制备治疗痛风草本植物制剂的方法 |
CN111317780A (zh) * | 2020-04-27 | 2020-06-23 | 广西本草坊保健品有限公司 | 一种调节尿酸的中药制剂 |
-
2021
- 2021-02-04 CN CN202110154677.0A patent/CN112813126B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112813126A (zh) | 2021-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112813126B (zh) | 一种火麻仁粕蛋白多肽液的生产方法和一种具有降尿酸作用的多肽液及其应用 | |
JP6759337B2 (ja) | 酵素生産能が優秀である伝統発酵食品由来の新たな菌株及びこれを用いた穀物発酵酵素食品の製造方法 | |
US20170267746A1 (en) | Techniques of preparing collagen active peptides | |
JP2018531036A6 (ja) | 酵素生産能が優秀である伝統発酵食品由来の新たな菌株及びこれを用いた穀物発酵酵素食品の製造方法 | |
CN109207544B (zh) | 一种小球藻抗氧化多肽的制备方法 | |
CN110495611A (zh) | 一种提高海参营养保健功效的工艺 | |
JP2009161448A (ja) | 麦芽根抽出物、その製造方法、およびそれを含んでなる微生物の発酵促進剤 | |
JP4313615B2 (ja) | 免疫賦活活性及びγ−アミノ酪酸産生能を有する新規乳酸菌、及びその利用。 | |
KR100710275B1 (ko) | 바실러스속 미생물을 이용한 대두피 또는 흑두피 발효방법,그리고 및 대두피 또는 흑두피 발효물을 함유하는 조성물 | |
KR101539820B1 (ko) | 혈전성 질환 예방 식품 | |
US11085033B2 (en) | Glycosylated oxalate decarboxylase and preparation and application thereof | |
CN103540569A (zh) | 结石酶及其制备方法 | |
CN106473023A (zh) | 一种具有降压抗凝血功能的海参卵发酵产物的制备方法 | |
CN1292673C (zh) | 玉米蛋白活性肽的制作方法 | |
JP5940871B2 (ja) | 大豆米糠発酵組成物及びその製造方法、並びに、抗高血圧組成物及び飲食品 | |
RU2758788C1 (ru) | Способ получения коллагенолитического фермента | |
CN114468279B (zh) | 一种诺丽果渣酵素及其制备方法 | |
KR100831420B1 (ko) | 혈전용해능을 갖는 바실러스 속 mk―15 | |
KR100780482B1 (ko) | 동치미 발효세균을 함유하는 청국장 | |
JP2018177741A (ja) | 疲労回復用組成物及び疲労回復用加圧酵素分解物を製造する方法 | |
Tillaeva et al. | THE PROSPECTS OF USING ENZYME PREPARATIONS IN COMBINATION WITH ANTI-INFLAMMATORY DRUGS IN MODERN PHARMACOTHERAPY | |
KR20170114559A (ko) | 당뇨병에 효과적인 세리포리아 락세라타 균사체 배양물 제조방법 | |
JP6035361B2 (ja) | Ace阻害剤の製造方法、及び、そのace阻害剤を含む含有物の製造方法 | |
Abu-Tahon et al. | Examination of thrombolytic and anticoagulant activities of purified fibrinolytic enzyme extracted from Cochliobolus hawaiiensis under solid state fermentation | |
JP2002121141A (ja) | 機能性素材、sod作用剤、血圧降下剤、血栓溶解剤及びその製造方法並びにその製造方法に用いる菌株 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230526 Address after: 300450 room 502-7, gate 1, building 4, Rongsheng Plaza, Binhai Zhongguancun Science Park, economic and Technological Development Zone, Binhai New Area, Tianjin Patentee after: TIANJIN PEIYANG BIOTRANS BIOTECH Co.,Ltd. Patentee after: TIANJIN University OF SCIENCE AND TECHNOLOGY Address before: No.9, 13th Street, Binhai New Area Economic and Technological Development Zone, Tianjin 300450 Patentee before: TIANJIN University OF SCIENCE AND TECHNOLOGY |